Type 1 and type 2 cytokines in HIV infection - A possible role in apoptosis and disease progression

Annals of Medicine

Volumn 29, Issue 3, 1997, Pages 185-188

  Clerici, Mario ^a,b   Fusi, Maria Luisa ^a   Ruzzante, Stefania ^a   Piconi, Stefania ^a   Biasin, Mara ^a   Arienti, Donatella ^a   Trabattoni, Daria ^a   Villa, Maria Luisa ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

AIDS; Apoptosis; Cytokines; Disease progression; HIV; Immunology

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; T LYMPHOCYTE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; DISEASE COURSE; ETIOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPEREOSINOPHILIA; MONONUCLEAR CELL; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030879177     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899708999334     Document Type: Short Survey

References (18)

1. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993; 57: 183-233.
2. Clerici M, Shearer GM. Is HIV associated with a TH1→TH2 switch? Immunol Today 1993; 14: 107-11.
3. Clerici M, Shearer GM. The TH1/TH2 model of HIV infection: new insights. Immunol Today 1994; 15: 575-81.
4. Mosmann TR, Coffman RI. Two types of mouse T helper cell clone: implication for immune regulation. Immunol Today 1987; 8: 223-6.
5. Mosmann TR, Coffman RI. TH1 and TH2 cells: different pattern of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-68.
6. Lane HC, Depper JM, Greene WC, et al. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome: evidence for a selective defect in soluble antigens recognition. N Engl J Med 1985; 313: 79-84.
7. Miedema F, Petit AJ, Terpstra FG, et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest 1988; 82: 1908-16.
8. Lucey DR, Melchers GP, Hendrix CW, et al. The US Air Force HIV study 1985-1990: immunological analyses, seroconversion and the potential utility of a T helper functional assay to predict change in CD4+ T-cell counts during early stages of HIV infection. J Infect Dis 1991; 164: 631-7.
9. Dolan MJ, Blatt SP, Hendrix CW, et al. In vitro T cell function, delayed type hypersensitivity skin testing, and CD4 T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis 1995; 172: 79-87.
10. Graziosi C, Pantaleo G, Gantt KR, et al. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV infected individuals. Science 1992; 265: 248-52.
11. Levy JA. HIV pathogenesis and long-term survival. AIDS 1993; 7: 1401-10.
12. Viganò A, Principi N, Villa ML, et al. Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression. J Pediatr 1995; 126: 368-74.
13. Tersmette M, De Goede REY, Al BJM, et al. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired imunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 1988; 62: 2026-32.
14. Koot, M. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993; 118: 681-8.
15. Clerici M, Balotta C, Salvaggio A, et al. HIV phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood (in press).
16. Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 1991; 12: 102-6.
17. Clerici M, Sarin A, Coffman RL, et al. Type 1/type 2 cytokine modulation of T cell programmed cell death as a model for HIV pathogenesis. Proc Natl Acad Sci USA 1994; 91: 11811-5.
18. Adachi Y, Oyazu N, Than S, McCloskey W, Pahwa S. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2. J Immunol 1996; 157: 4184-93.